Evidence map›Paper›PMID 34920989›Full record

ArticleBJGP open2022

Point-of-care testing, antibiotic prescribing, and prescribing confidence for respiratory tract infections in primary care: a prospective audit in 18 European countries.

Alike W van der Velden, Alma C van de Pol, Emily Bongard, Daniela Cianci, Rune Aabenhus, Anca Balan, Femke Böhmer, Valerija Bralić Lang, Pascale Bruno, Slawomir Chlabicz and 18 more

Open access · goldAbstract read
In one paragraph

Article in BJGP open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 3 pooled it
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 3 syntheses or guidelines pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Implementing in-vitro diagnostic point-of-care tests in community health care: how can we make this work?The British journal of general practice : the journal of the Royal College of General Practitioners · 2025
    Article
  14. Article
  15. Article
  16. Antivirals to prepare for surges in influenza cases: an economic evaluation of baloxavir marboxil for the Netherlands.The European journal of health economics : HEPAC : health economics in prevention and care · 2024
    Article
  17. Article
  18. Observational
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 18 institutions in 16 countries.

Alike W van der VeldenJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands a.w.vandervelden@umcutrecht.nl.
Alma C van de PolJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
Emily BongardNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Daniela CianciJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
Rune AabenhusDepartment of Public Health, University of Copenhagen, Copenhagen, Denmark.
Anca BalanBalan Medfam SRL, Cluj Napoca, Romania.
Femke BöhmerInstitute of General Practice, Rostock University Medical Center, Rostock, Germany.
Valerija Bralić LangDepartment of Family Medicine, Andrija Stampar School of Public Health, School of Medicine, University of Zagreb, Zagreb, Croatia.
Pascale BrunoDépartement de Santé Publique, Centre Hospitalier Universitaire de Nice, Nice, France.
Slawomir ChlabiczDepartment of Family Medicine, Medical University of Bialystok, Bialystok, Poland.
Samuel CoenenDepartment of Family Medicine and Population Health, University of Antwerp, Antwerp, Belgium.ORCID https://orcid.org/0000-0002-1238-8052
Annelies ColliersDepartment of Family Medicine and Population Health, University of Antwerp, Antwerp, Belgium.
Ana García-SangenísInstitut Universitari d'Investigació en Atenció Primària Jordi Gol, Barcelona, Spain.
Hrachuhi GhazaryanWigmore Clinic, Yerevan, Armenia.
Maciej Godycki-ĆwirkoCentre for Family and Community Medicine, Faculty of Health Sciences, Medical University of Lodz, Lodz, Poland.
Siri JensenThe Antibiotic Centre for Primary Care, Department of General Practice, University of Oslo, Oslo, Norway.
Christos LionisClinic of Social and Family Medicine, School of Medicine, University of Crete, Crete, Greece.
Sanne R van der LindeJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
Lile MalaniaNational Center for Disease Control and Public Health, Tbilisi, Georgia.
Jozsef PauerDRC Drug Research Centre, Balatonfüred, Hungary.
Angela TomacinschiiUniversity Clinic of Primary Medical Assistance, Nicolae Testemițanu State University of Medicine and Pharmacy, Chișinău, The Republic of Moldova.
Akke VellingaSchool of Medicine, National University of Ireland, Galway, Ireland.
Ihor ZastavnyyNGO Academy of Family Medicine of Ukraine, Lviv, Ukraine.
Susanne EmmerichAbbott Rapid Diagnostics Germany GmbH, Cologne, Germany.
Adam ZerdaAMR Strategy & Development, Becton Dickinson and Co, North Carolina, NC, US.
Theo J VerheijJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0002-0166-1498
Herman GoossensLaboratory of Medical Microbiology, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.
Christopher C ButlerNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
University Medical Center Utrecht · NLUniversity of Antwerp · BEUniversity of Oxford · GBAbbott (Germany) · DEBecton Dickinson (United States) · USCentre Hospitalier Universitaire de Nice · FRInstitut Universitari d'Investigació en Atenció Primària Jordi Gol · ESMedical University of Białystok · PLMedical University of Lodz · PLNicolae Testemițanu State University of Medicine and Pharmacy · MDOllscoil na Gaillimhe – University of Galway · IETbilisi State University · GEUniversity of Copenhagen · DKUniversity of Crete · GRUniversity of Oslo · NOUniversity of Rostock · DEUniversity of Zagreb · HRYerevan State Medical University · AM

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBetween-country differences have been described in antibiotic prescribing for respiratory tract infection (RTI) in primary care, but not yet for diagnostic testing procedures and prescribing confidence.

aimTo describe between-country differences in RTI management, particularly diagnostic testing and antibiotic prescribing, and investigate which factors relate to antibiotic prescribing and GPs' prescribing confidence. DESIGN &

settingProspective audit in 18 European countries.

methodAn audit of GP-registered patient, clinical, and management characteristics for patients presenting with sore throat and/or lower RTI (

resultsAntibiotic prescribing proportions varied considerably: <20% in four countries, and >40% in six countries. There was also considerable variation in point-of-care (POC) testing (0% in Croatia, Moldova, and Romania, and >65% in Denmark and Norway, mainly for C-reactive protein [CRP] and group A streptococcal [strep A] infection), and in laboratory or hospital-based testing (<3% in Hungary, the Netherlands, and Spain, and >30% in Croatia, Georgia, Greece, and Moldova, mainly chest X-ray and white blood cell counting). Antibiotic prescribing was related to illness severity, comorbidity, age, fever, and country, but not to having performed a POC test. In nearly 90% of consultations, GPs were confident in their antibiotic prescribing decision.

conclusionDespite high confidence in decisions about antibiotic prescribing, there is considerable variation in the primary care of RTI in European countries, with GPs prescribing antibiotics overall more often than is considered appropriate. POC testing may enhance the quality of antibiotic prescribing decisions if it can safely reverse decisions confidently made on clinical grounds alone to prescribe antibiotics.

Indexed as

anti-bacterial agentsauditconfidenceC-reactive proteindiagnosticsGPgroup A streptococcusprimary health carerespiratory tract infections

Identifiers

PMID34920989
PMCPMC9447323
OpenAlexW4200000460

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.